Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Royalty Pharma plc (RPRX)

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-12-18 ADAGE CAPITAL PARTNERS GP, L.L.C. 10%-Owner Sell 7,301,050 $43.92 $320,672,221 No
2020-10-20 RIGGS RORY B Director Sell 463,200 $42.00 $19,454,400 No
2020-10-20 RIGGS RORY B Director Sell 463,200 $42.00 $19,454,400 Yes
2020-06-18 Coyne Terrance P. EVP & CFO Buy 2,950 $28.00 $82,600 Yes
2020-06-18 RIGGS RORY B Director Buy 15,000 $28.00 $420,000 Yes
2020-06-18 Hite Christopher EVP & Vice Chairman Buy 70,000 $28.00 $1,960,000 Yes
2020-06-18 Legorreta Pablo G. CEO, Chairman of the Board Buy 20,000 $28.00 $560,000 Yes
2020-06-18 FORD WILLIAM E Director Buy 1,500,000 $28.00 $42,000,000 Yes
2020-06-18 Lloyd George W. EVP, Investments & GC Buy 14,200 $28.00 $397,600 Yes
2020-06-18 Giuliani Mario Germano 10%-Owner, Director Buy 50,000 $28.00 $1,400,000 Yes
2020-06-18 ADAGE CAPITAL PARTNERS GP, L.L.C. 10%-Owner Buy 3,000,000 $28.00 $84,000,000 Yes

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.